IMC Chicago’s Charles River Laboratories CRL Stock Holding History

IMC Chicago’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.21M	Sell	7,000 -3,200	-31%	-$593K	﹤0.01%	3076
2025 Q4	$2.03M	Sell	10,200 -100	-1%	-$18.1K	﹤0.01%	2404
2025 Q3	$1.61M	Sell	10,300 -1,800	-15%	-$286K	﹤0.01%	2386
2025 Q2	$1.84M	Buy	+12,100	New	+$1.61M	﹤0.01%	2072

Other funds holding CRL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

IMC Chicago's CRL Position: Q1 2026 in Review

IMC Chicago opened a new position in Charles River Laboratories (CRL) in Q1 2026: 7,293 shares worth $1.26M. The stake represents ﹤0.01% of the portfolio and ranks #3043 among its holdings.

557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

IMC Chicago held 7,293 shares of Charles River Laboratories worth $1.26M as of Q1 2026.
Charles River Laboratories was a new IMC Chicago position in Q1 2026.
Charles River Laboratories made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #3043 holding.
557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.